Product Reports Resources Pricing Login Book a demo

Twist Bioscience

Biotech & Life Sciences · South San Francisco, United States · Founded 2013 · IPO 2018

Develops a proprietary semiconductor-based synthetic DNA manufacturing process

Valuation $5.63B
Revenue $445M
Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue
Knowledge graph
News Twist Bioscience taps public markets for $250M share sale Aug 4, 2026

Talent graph

Twist Bioscience's talent

Book a demo to see the people
Employees mapped 1,305 incl. 7 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 6 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

19 investors on Twist Bioscience's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage
ARCH Venture Partners
Asset Management Ventures
Paladin Capital Group
Series B+ 16 investors entered at this stage
Tao Venture Partners
Boris Nikolic
ARCH Overage Fund
FIS
WuXi Healthcare Ventures
Joby Pritzker
Reinet Investments S.C.A.
Dentsu Ventures
+ND Capital
3W Partners
Biomatics Capital Partners
Illumina Ventures
Cormorant Asset Management
Foresite Capital
Yuri Milner
Illumina

Twist Bioscience mafia

Startups founded by Twist Bioscience alumni

Former Twist Bioscience employees who went on to start their own companies. Sorted by Dealroom signal score.

Atlas Data StorageEst. 2025
Bill BanyaiUnited States
Signal score87
ManaEst. 2021
YDYogev DebbiIsrael
Signal score74
BristleEst. 2020
Brian MaurerUnited States
Signal score68
Switchback SystemsEst. 2019
Eugene MarshUnited States
Signal score62
RubrYc TherapeuticsEst. 2017
IBIsaac BrightUnited States
Signal score56
IronblocksEst. 2022
Assaf EliIsrael
Signal score55

Book a demo to explore the full alumni network →

Global footprint

Where Twist Bioscience has talent and traffic

Workforce by country
25 countries with
team presence
🇺🇸 United States84.6%
🇬🇧 United Kingdom2.7%
🇩🇪 Germany1.9%
🇸🇬 Singapore1.5%
🇮🇱 Israel1.3%
Top 5 of 25 shown
Web traffic by country
160K monthly visits
across markets
🇺🇸 United States30.4%
🇬🇧 United Kingdom7.3%
🇮🇳 India7.3%
🇳🇴 Norway5.5%
🇦🇺 Australia5.3%
Top 5 markets shown

Patent intelligence

$89M patent portfolio · 108 active families

Estimated portfolio value
$89M
1.6% of market cap · 26.8× smaller than top peer Illumina ($2.4B)
108 active patent families
Where Twist Bioscience innovates BioinformaticsBiological organismCellLibraryMolecular biology

Where Twist Bioscience concentrates vs peers

Each axis is a top-10 topic across Twist Bioscience and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Twist Bioscience's 5 investments and acquisitions.

Every disclosed deal where Twist Bioscience appeared as a backer or acquirer, 2016–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across Twist Bioscience's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Twist Bioscience deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Twist Bioscience's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        5 of 5 deals

        Market sentiment

        What the market is saying about Twist Bioscience

        An AI-synthesized read of the highest-engagement posts about Twist Bioscience on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Twist Bioscience on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles